Trademark: MOLECULAR CANCER THERAPEUTICS
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
MOLECULAR CANCER THERAPEUTICS
Click here to search for trademarks similar to MOLECULAR CANCER THERAPEUTICS
Proof of use for MOLECULAR CANCER THERAPEUTICS
We do not have any records of a proof of use for MOLECULAR CANCER THERAPEUTICS at this moment.
Click here to add a proof of use for MOLECULAR CANCER THERAPEUTICS
Possible trademark infringements of MOLECULAR CANCER THERAPEUTICS
Basic Information about MOLECULAR CANCER THERAPEUTICS
- Serial Number
- 76051350
- Filing Date
- 18 May 2000
- Registration Number
- 2596253
- Registration Date
- 16 Jul 2002
- Mark Drawing Code
- 1
Classifications
Declare the trademark use of MOLECULAR CANCER THERAPEUTICS on the blockchain with WikiTrademarks.io.
- First use of MOLECULAR CANCER THERAPEUTICS anywhere
- MOLECULAR CANCER THERAPEUTICS was first used on 30 Oct 2001 for the primary classification of goods and services, international, 016 (Paper goods and printed matter)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 016
- US Codes
- 002; 005; 022; 023; 029; 037; 038; 050
- First use of MOLECULAR CANCER THERAPEUTICS anywhere
- MOLECULAR CANCER THERAPEUTICS was first used on 13 Nov 2001 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns MOLECULAR CANCER THERAPEUTICS?
1. American Association for Cancer Research, Inc. Philadelphia PA
2. American Association for Cancer Research, Inc. Philadelphia PA
Correspondent
- Mark A. Steiner, Esq.
- Duane Morris LLP
- Spear Tower, One Market Plaza, Ste. 2200
- San Francisco, CA 94105-1127
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io